The Latest Cardiac and Vascular News
NORTHVILLE, Mich., May 28, 2020 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), a global market leader and developer of innovative thermal management technologies today announced that via the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA), the Company’s Hemotherm® Model 400CE Dual Reservoir Cooler-Heater can be used to treat patients […]
PERSIST-AVR study results presented at American Association for Thoracic Surgery Annual Meeting LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, presented the first data from the Perceval® Sutureless Implant Versus Standard-Aortic Valve Replacement (PERSIST-AVR) clinical study at the 100th Annual Meeting of the American Association of Thoracic Surgery (AATS). The study demonstrated that the […]
Medtronic sponsors research aimed at improving patient outcomes ADDISON, Texas, May 28, 2020 (GLOBE NEWSWIRE) — Jordan R.H. Hoffman, MD, Assistant Professor in Cardiac Surgery at Vanderbilt University School of Medicine in Nashville, TN., has received the O.H. Frazier Award in MCS Translational Research sponsored by Medtronic and administered by […]
EDEN PRAIRIE, Minn., May 28, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with Transimed Medical Equipment Co. LLC covering the United Arab Emirates, the first distribution partnership in the Middle East region. The company now has distribution agreements covering 14 countries […]
Ghent, BELGIUM – 28 May 2020 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, announces that all proposed resolutions submitted to the Annual and Extraordinary General Meeting of Shareholders were approved […]
NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported financial, corporate and operational highlights for the nine months ended March 31, 2020. Cash on hand at March 31, 2020 was US$60.1 million (A$97.3 million) and in […]
Pharmaceutical industry leader to join as the Company prepares for the Phase II clinical trial with merimepodib, an orally administered broad-spectrum anti-viral for COVID-19 Westport, CT, May 28, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) today appointed Mr. Michael R. Dougherty to the Board […]
May 28, 2020 Support provided by the Philips Foundation helped 5 million more people to access one or more healthcare services in 2019 Almost 900,000 lives were improved as a result of the foundation’s 2018-2019 employee volunteering program to fight childhood pneumonia Additional 38 projects launched in 2019 to explore […]
BASKING RIDGE, N.J., May 28, 2020 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced that it has closed on its previously announced sale of an aggregate of […]
CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Hikma Pharmaceuticals PLC (Hikma, Group) to supply amiodarone and sterile water to healthcare providers, helping to stabilize the long-term supply of two medications vital for COVID-19 patient care. Amiodarone is used to manage late onset cardiac arrest and […]
